HM95573 in Combination With Either Cobimetinib or Cetuximab in Patients With Locally Advanced or Metastatic Solid Tumors

Clinical trial NCT03284502 · UNKNOWN

Trial details

NCT number: NCT03284502
Sponsor: Hanmi Pharmaceutical Company Limited
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced Solid Tumor Metastatic Solid Tumor

Start date: 2017-05-22
Primary completion: 2024-09-30
Enrollment: 148

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.